In the January 2020 edition of STAT News was a news release from 215 biopharma CEOs and industry leaders. The news release leverages 2020 as the beginning of “the dawn… Read More »
A primary goal of rheumatologists remains alleviating the pain, stiffness and tenderness that mark rheumatoid arthritis (RA). Yet in an era marked by a significant increase in self-injection options,… Read More »
Millions of patients worldwide living with rare, debilitating conditions are benefiting from developments in biopharmaceuticals and complex chemical entities as well as novel approaches to drug delivery. For example,… Read More »
Chronic illnesses are on the rise, which means there are more and more patients who need to self-inject treatments at home. The problem is that patients who lack confidence in… Read More »
Participants in a study by the company Noble show that the vast majority of patients—92%—would prefer to bring home a training device to practice with prior to starting self-injection. Noble creates… Read More »
Joe Reynolds leverages the knowledge of the pharmaceutical and medical device industries to derive insights and maximize value for all members of the Noble healthcare team. His experience includes work… Read More »